The indicators on glutathione (GSH) have been pointing in the same direction for years: The major redox couple has been widely available in pharmaceuticals and supplements, offering benefits that range from discharging toxins and expunging free radicals from the system, to promoting healthy aging, managing stress, bolstering liver function, beautifying the complexion, and re-energizing exhausted muscles. Though the empirical evidence has been overpowering, new science-based studies and support have been unavailable until now, thanks to successive studies conducted by KOHJIN Life Sciences.
Addressing the International Union of Nutritional Science conference in Grenada, Spain, this past September, researchers from KOHJIN Life Sciences and Kyoto Prefectural University presented a report of their laboratory and in vivo studies that made them the first researchers ever to tip the balance to certainty in the matter of GSH’s ability to restore muscular energy through oral intake and absorption; shining brighter light on the path forward for the tripeptide’s playing a dominant role in everyday orally administered health care supplementation based on our human study. The studies demonstrate, for the first time, mitochondrial biogenesis associated with the ingestion of a food product. They show that oral intake of GSH (KOHJIN Glutathione) resulted in a PGC-1α expression in skeletal muscle, which can lead to acceleration of lipid utilization through activation of mitochondrial aerobic metabolism.
For nearly a half century KOHJIN Life Sciences, a wholly owned subsidiary of the Mitsubishi Corporation, has developed its reputation as the pioneer research group studying the benefits of GSH. The company’s signature process of L-glutathione derivation from Torula yeast, its quality, consistency, and multiple internationally recognized dietary certifications have all contributed to KOHJIN glutathione’s becoming the world’s largest selling GSH, and KOHJIN one of the field’s most trusted names.
KOHJIN will be hosting a seminar at this year’s SupplySide West on Nov. 14 at 4:30 p.m. (booth #15075) to discuss these game-changing studies, which constitute the most significant news to reach the community about GSH since the earliest days of its development.
In brief, though GSH has a long history as a natural supplement to improve liver function and skin whitening, no significant increase of GSH has been detected in human blood after oral ingestion, leaving the benefits of GSH supplementation in question. By following the path of protein conjugates in blood serum, KOHJIN Life Science’s research was able, for the very first time, to demonstrate conclusively its increased presence in human blood plasma following ingestion. The implications of this study are both stunning and hugely encouraging to all those involved in the future of functional food supplementation.
Please visit the KOHJIN Life Sciences booth, #28001, at SupplySide West to learn more. Formulators and manufacturers have trusted KOHJIN Glutathione for years. With these studies their confidence has been rewarded with conviction, and makers and consumers alike can look to greater and more varied ways to partake of GSH’s benefits on a daily basis going forward.